- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02274220
Feeding Study - Effects Post-cardiac Surgery
May 23, 2018 updated by: Alejandro Floh, The Hospital for Sick Children
Randomized Study of Early Nutritional Delivery on Glucose Control, Insulin Resistance and Systemic Inflammation Following Pediatric Cardiac Surgery
The purpose of this randomized trial is to clarify the role of enteral nutrition (EN) on the relationship between cardiopulmonary bypass-induced inflammation and insulin resistance by investigating the effects of two different feeding strategies in infants following cardiac surgery.
The study's primary objective is to determine if early and higher volume feeding modifies the relationship between the severity of postoperative systemic inflammation and insulin resistance.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Good nutrition is important for patients after surgery.
Patients who are given food tend to have fewer infections, better wound healing, and are possibly discharged more quickly from the intensive care unit and hospital.
However, the best time to start feeds and the speed at which they can be increased is unclear.
This may be particularly true for young children who have undergone heart surgery using a heart-lung bypass machine (bypass surgery).
Bypass surgery can cause inflammation that can change the way the body uses energy and nutrients.
Specifically, after bypass the body can become insensitive to insulin (insulin resistant), which means that the cells in the body don't take up sugar from the blood like they are supposed to, and this may lead to complications from the surgery.
In a recent study we found that inflammation and insulin resistance was not associated with as many complications in children who were being fed.
We are not sure if feeding changed the way in which the body responded after surgery or if doctors chose to feed only patients who were already recovering well.
In general, doctors often hesitate to feed patients immediately after surgery because they worry that the body may not be ready for food although there is not much information to prove that this worry is correct.
Starting feeds early using a structured feeding plan may be good during the recovery from heart surgery, even in our most vulnerable patients.
We therefore designed this study to see if starting feeds early after bypass surgery and increasing them more quickly than our usual routine would decrease inflammation and insulin resistance.
We will only study children younger than 6 months of age because they are at higher risk of complications from bypass surgery.
Study Type
Interventional
Enrollment (Actual)
86
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5G 1X8
- The Hospital for Sick Children
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 minute to 6 months (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- less than 6 months of age
- weight > 2.5kg
- surgery using cardiopulmonary bypass
- expected duration of ventilation > 6 hours
Exclusion Criteria:
- cardiac transplantation
- prematurity (<37 weeks gestation AND under 28 days of life)
- intrauterine growth restriction
- NEC
- structural gastrointestinal anomalies
- known preoperative feeding intolerance
- diabetes or known metabolic disorder
- preoperative liver or renal dysfunction
- postoperative contraindication to enteral feeding as determined by clinical team
- previous enrollment at an earlier operation
- in the opinion of the clinical or research team the patient is too well to participate, such that slow escalation to feeds would lead to hunger and therefore be considered inappropriate.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Rapid Advancement of Feeds
Postoperative feeds are initiated on first postoperative day and rapidly advanced over 27 hours.
|
Feeding is initiated on first postoperative day.
Bolus feeds are started at 1 mL/kg every three hours and up-titrated by 1 mL/kg every feed (Q 3 hours) to a goal of 10 mL/kg/feed (equivalent to approximately 50 kcal/kg/day).
Feeding volume will exceed 20 mL/kg/day by 6 hours following protocol initiation and reach target feeds by 27 hours of protocol initiation.
|
|
Experimental: Average feeding protocol
Postoperative feeds are initiated on first postoperative day and advanced in using a standardized protocol that best-reflects current feeding practice.
Maximum feeding volume is reached at 60 hours.
|
Feeding is initiated on first postoperative day.
Bolus feeds are started at 3 mL every three hours for 24 hours.
Bolus feeds then up-titrated by 1 mL/kg every-other feed (Q 6 hours) for 24 hours.
Bolus feeds then up-titrated by 1mL/kg every feed for to a goal of 10 mL/kg/feed (equivalent to approximately 50 kcal/kg/day).
Feeding volume will reach target feeds by 60-63 hours after protocol initiation.
|
|
No Intervention: Feeds not affected
Postoperative feeds for patients not eligible for randomization are initiated by the treating clinical team and increased as per clinical team's preference.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Insulin resistance
Time Frame: 96 hours
|
Plasma insulin concentrations and glucose-insulin ratio (GIR) - GIR will be calculated at each time point and used to reflect insulin resistance, with lower values representing increased resistance
|
96 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative systemic inflammation
Time Frame: 96 hours
|
Serial measurements of postoperative cytokine (IL-1beta, IL-6, IL-8, IL-10 and TNFalpha) concentrations
|
96 hours
|
|
Cardiac output
Time Frame: 96 hours
|
Postoperative cardiac output measured by respiratory mass spectrometry and Fick equation
|
96 hours
|
|
Morbidity score
Time Frame: 96 hours
|
Postoperative morbidity assessed by a composite morbidity score that includes death, cardiac arrest, use of extracorporeal membrane oxygenation, cardiogenic shock, acute kidney injury, hepatic injury, or hospital-acquired infection.
|
96 hours
|
|
Number of subjects achieving goal feeds
Time Frame: 96 hours
|
96 hours
|
|
|
Number of subjects with NEC/feeding intolerance/protocol violations
Time Frame: 96 hours
|
96 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Steve Schwartz, MD, The Hospital for Sick Children
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2014
Primary Completion (Actual)
March 1, 2017
Study Completion (Actual)
April 1, 2017
Study Registration Dates
First Submitted
October 20, 2014
First Submitted That Met QC Criteria
October 22, 2014
First Posted (Estimate)
October 24, 2014
Study Record Updates
Last Update Posted (Actual)
May 25, 2018
Last Update Submitted That Met QC Criteria
May 23, 2018
Last Verified
May 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1000046036
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.